Page last updated: 2024-08-05 15:14:40

EC 1.14.13.132 (squalene monooxygenase) inhibitor

An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of squalene monooxygenase (EC 1.14.13.132).

ChEBI ID: 59285

Members (5)

MemberDefinitionClass
butenafineTrimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.butenafine
locerylA member of the class of morpholines that is cis-2,6-dimethylmorpholine in which the hydrogen attached to the nitrogen is replaced by a racemic 2-methyl-3-[p-(2-methylbutan-2-yl)phenyl]propyl group. An inhibitor of the action of squalene monooxygenase, Delta(14) reductase and D7-D8 isomerase and an antifungal agent, it is used (generally as its hydrochloride salt) for the topical treatment of fungal nail and skin infections.amorolfine
naftifineA tertiary amine in which the nitrogen is substituted by methyl, alpha-naphthylmethyl, and (1E)-cinnamyl groups. It is used (usually as its hydrochloride salt) for the treatment of fungal skin infections.naftifine
terbinafineA tertiary amine that is N-methyl-1-naphthalenemethylamine in which the amino hydrogen is replaced by a 3-(tertbutylethynyl)allyl group. An antifungal agent administered orally (generally as the hydrochloride salt) for the treatment of skin and nail infections.terbinafine
terbinafine hydrochlorideA hydrochloride obtained by reaction of terbinafine with one molar equivalent of hydrogen chloride.terbinafine hydrochloride

Research

Studies (2,274)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-1990103 (4.53)18.7374
1990's516 (22.69)18.2507
2000's681 (29.95)29.6817
2010's678 (29.82)24.3611
2020's296 (13.02)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials365 (14.11%)5.53%
Reviews337 (13.03%)6.00%
Case Studies618 (23.89%)4.05%
Observational2 (0.08%)0.25%
Other1,265 (48.90%)84.16%

Protein Targets (73)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
activating transcription factor 6Homo sapiens (human)Potency13.153012
AR proteinHomo sapiens (human)Potency28.368766
aryl hydrocarbon receptorHomo sapiens (human)Potency29.849311
Cellular tumor antigen p53Homo sapiens (human)Potency20.188713
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.011211
chromobox protein homolog 1Homo sapiens (human)Potency15.848911
cytochrome P450 2C9, partialHomo sapiens (human)Potency20.964613
cytochrome P450 2D6Homo sapiens (human)Potency1.685113
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency18.032125
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency33.491511
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.125111
DNA polymerase kappa isoform 1Homo sapiens (human)Potency39.810711
estrogen nuclear receptor alphaHomo sapiens (human)Potency29.215366
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency33.491511
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency25.756533
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.981111
farnesoid X nuclear receptorHomo sapiens (human)Potency18.832211
Fumarate hydrataseHomo sapiens (human)Potency23.485011
GVesicular stomatitis virusPotency20.964613
gemininHomo sapiens (human)Potency15.944723
GLI family zinc finger 3Homo sapiens (human)Potency26.603222
glp-1 receptor, partialHomo sapiens (human)Potency14.125411
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency15.316124
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency25.118912
Histone H2A.xCricetulus griseus (Chinese hamster)Potency55.562812
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency20.964613
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency26.832522
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency20.964616
Interferon betaHomo sapiens (human)Potency20.964613
lamin isoform A-delta10Homo sapiens (human)Potency9.984212
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency31.650523
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency18.449613
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency22.874122
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency12.030535
ParkinHomo sapiens (human)Potency22.387211
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency20.314811
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency28.701722
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency33.488911
PINK1Homo sapiens (human)Potency22.387211
polyproteinZika virusPotency23.485011
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency25.118911
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency11.040613
pregnane X nuclear receptorHomo sapiens (human)Potency14.096625
progesterone receptorHomo sapiens (human)Potency33.491511
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency89.125111
RAR-related orphan receptor gammaMus musculus (house mouse)Potency31.039612
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency21.575634
retinoid X nuclear receptor alphaHomo sapiens (human)Potency9.085924
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency39.810712
TDP1 proteinHomo sapiens (human)Potency31.334928
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency24.691626
thyroid stimulating hormone receptorHomo sapiens (human)Potency29.849322
USP1 protein, partialHomo sapiens (human)Potency42.166824
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency15.218025

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseHomo sapiens (human)Ki25.750012
AcetylcholinesteraseHomo sapiens (human)IC506.907111
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC504.019712
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)Ki3.986412
Alpha-2A adrenergic receptorHomo sapiens (human)IC504.673612
Alpha-2A adrenergic receptorHomo sapiens (human)Ki1.752612
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50133.000011
Bile salt export pumpHomo sapiens (human)IC50133.000011
C-8 sterol isomeraseSaccharomyces cerevisiae S288CKi25.155012
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50133.000011
cystic fibrosis transmembrane conductance regulatorHomo sapiens (human)IC5025.000011
Cytochrome P450 2D6Homo sapiens (human)IC500.250012
Enoyl-[acyl-carrier-protein] reductase [NADH] Francisella tularensis subsp. tularensis SCHU S4IC5076.000011
Multidrug resistance-associated protein 4Homo sapiens (human)IC50133.000011
Sigma non-opioid intracellular receptor 1Homo sapiens (human)IC502.256812
Sigma non-opioid intracellular receptor 1Homo sapiens (human)Ki0.925623
Sodium-dependent noradrenaline transporter Homo sapiens (human)IC504.019712
Sodium-dependent noradrenaline transporter Homo sapiens (human)Ki3.986412
Sodium-dependent serotonin transporterHomo sapiens (human)IC501.411811
Sodium-dependent serotonin transporterHomo sapiens (human)Ki0.750011
Squalene monooxygenaseCandida albicans SC5314IC500.317011
Squalene monooxygenaseHomo sapiens (human)IC506.000011
Squalene monooxygenaseHomo sapiens (human)Ki0.030011
Squalene monooxygenase Rattus norvegicus (Norway rat)IC5093.000011

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
heat shock protein 90Candida albicansEC502.591011